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Objectives: To use the autologous gastroepiploic artery (GEA) as arterial bypass graft for peripheral revascularisation. 
We compared the development of intimal hyperplasia and nitric oxide (NO) capacity in GEA and internal jugular vein 
(IJV) implanted as peripheral grafts. 
Materials and methods: In pigs the GEA was implanted into the right peripheral circulation as a femoropopliteal 
bypass graft. In the left peripheral circulation the IJV was implanted as a femoropopliteal graft. After 2i days all grafts 
were harvested. Vascular ings of each graft before and after operation were studied for NO capacity. The distal half of 
each graft was prepared for histomorphometric studies. 
Results: Administration of bradykinin to IJV and GEA induced relaxation. After implantation bradykinin resulted in 
contraction i  IJV grafts, whereas in GEA grafts relaxation was reduced. In IJV grafts extensive intimaI hyperplasia was 
formed, whereas in GEA grafts only small areas of intimal hyperplasia were formed. 
Conclusions: The functional studies lost NO capacity in IJV grafts, whereas NO capacity in GEA grafts remained 
intact. Intimal hyperplasia in IJV grafts was extensive, whereas GEA grafts demonstrated preservation of pre-existent 
intimaI architecture. These results may encourage the application of the human GEA as bypass graft for reconstruction 
of arteries in the lower limb or foot. 
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Introduction 
Autologous vein is regarded as the bypass graft of 
choice for peripheral revascularisation, especially for 
revascularisation in the lower limb or foot. However, 
vein graft failure due to intimal hyperplasia is a com- 
mon event. 1Functional changes in the vein graft endo- 
theliurn are also implicated in peripheral vein graft 
failure. For example, it is known that vein graft endo- 
thelium is unable to produce nitric oxide. Nitric oxide 
is an important contributor to the regulation of the 
vascular tone and helps to provide a non-thrombogenic 
luminal surface. In addition, nitric oxide is able to 
inhibit vascular smooth muscle cell proliferation. 2 Im- 
pairment of nitric oxide release may deprive the vein 
graft of optimal protection against platelet adhesion 
and vasospasm and possibly occlusion. 
Recently it has been shown that the short-term 
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outcome of the gastroepiploic artery (GEA) utilised 
for human coronary bypass surgery is comparable 
with the successful se of the internal mammary artery 
(IMA) for coronary bypass grafting. 3 Histological, mor- 
phometric and  functional similarities suggest heir 
long-term patencies may be comparable. 4-6We pos- 
tulated that the gastroepiploic artery is a viable, novel 
bypass graft for peripheral revascularisation. There- 
fore, we compared the intimal morphology and endo- 
thelial nitric oxide function in the GEA and internal 
jugular vein before and after implantation as peri- 
pheral bypass grafts in a porcine model. 
Materials and Methods 
Experimental design 
Twelve female pigs (42.2+0.9kg) were used in this 
study. In the right femoropopliteal circulation the an- 
imals received the gastroepiploic artery as autologous 
arterial bypass graft. In the left femoral circulation the 
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internal jugular vein was implanted as a venous bypass 
graft. After 21 days all grafts were harvested. The 
proximal half of the grafts before and after grafting 
were used for determination of endothelial function. 
The distal half of the grafts was prepared for light 
microscopic and histomorphometric analysis. The ex- 
periments were approved by the committee for judg- 
ment of animal experiments of the Medical School, 
Groningen. 
Animal operations 
The animals were anaesthetised by an intravenous 
injection of sodium pentobarbital. The pigs were in- 
tubated and inhalation anaesthesia was accomplished 
with 1% halothane. An incision was made from the 
last nipple to the knee in both the right and left hind 
leg, exposuring the popliteal artery. Thereafter the 
adductor magnus muscle was partly dissected free 
from its fascia and mobilised to expose the femoral 
artery. A limited laparotomy was made approximately 
10cm distal of the xiphoid process. The peritoneal 
cavity was opened and the GEA palpated gently to 
determine its diameter. The GEA was dissected with 
the use of two surgical clips (Ethicon, Inc., Sommer- 
ville, NY, U.S.A.) on each branch, to the stomach and 
omentum, respectively. The branches were divided by 
electrocoagulation. The GEA was dissected to the left, 
two-thirds of the distance along the great curvature 
of the stomach. A solution of papaverine (0.ling/ 
ml saline) was gently injected into the fatty tissue 
surrounding the GEA to prevent spasm of the artery. 
The right internal jugular vein was harvested via a 
longitudinal incision medial to the right sterno- 
cleidomastoid muscle. During the preparation of the 
IJV, the vein did not go into spasm. Therefore we did 
not use papavarine in the preparation of the IJV. 
After systemic heparinisation with 5000 units hep- 
arin, the GEA was implanted as a peripheral arterial 
bypass graft with the help of optical magnification 
(x 2). There was an evident mismatch between the 
internal diameters of the GEA and the femoral rtery. 
The GEA with a length of approximately 5cm was 
implanted as bypass graft with an end-to-side ana- 
stomosis to the femoral artery and end-to-side to the 
popliteal artery above the knee using running 7-0 
polypropylene sutures (Ethicon, Inc.) (Fig. 1). The 
femoral artery between the bypass graft was clipped 
(Ethicon, Inc.), allowing blood flow only through the 
bypass. Approximately 5cm of the internal jugular 
vein was implanted as venous bypass graft into the 
left femoropopliteal arterial circulation using the same 
Fig. 1. Angiography demonstrating the gastroepiploic artery (arrow) 
as an arterial bypass graft in the femoral rtery. 
implantation technique as described above. The in- 
ternal diameter of the venous graft matched closely 
with the recipient femoral artery. The patency of all 
bypass grafts immediately after implantation was con- 
firmed by Doppler. The wounds were closed in layers 
using 2-0 polyglactin suture (Ethicon, Inc.). 
Postoperative anticoagulation treatment consisted 
of acetyl salicyclic acid 200mg daily starting the day 
after operation. Twenty-one days after the operation 
all the animals were reanaesthetised. The grafts were 
dissected and gently rinsed with normal saline. Sub- 
sequently the graft was divided in a proximal half 
for in vitro endothelial studies and a distal half for 
histologic examination. 
Histology 
The part for histological examination was fixed by 
immersion in 4% formalin for 48 h. The grafts were 
paraffin embedded and orientated for transversal sec- 
tioning. Sections were cut at 4 gm and stained for 
light microscopic examination with haematoxylin and 
eosin, and with modified Verhoeff's elastic tissue 
stains. The thickness and the area of the intima and 
the media of each graft were quantified by video- 
morphometry. The inner intimal boundary was the 
luminal surface, and the intima-media boundary was 
identified by the internal elastic lamina demarcated 
by the Verhoeff elastin staining. The outer border of the 
IJV graft was defined by the perivascular capillaries, 
whereas the outer border of the GEA graft was the 
outer elastic lamina. 
Endothelial fi~nction 
Both during the initial operation for peripheral re- 
vascularisation and at the time of sacrifice, segments 
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of the internal jugular vein and gastroepiploic artery 
were harvested for determination f preoperative (i.e. 
control) versus postoperative (i.e. graft) vessel func- 
tion. The collected blood vessels were placed in a 
buffer solution of the following composition (raM): 
NaC1, 120.4; KC1, 5.9; CaCI2, 2.5; MgC12, 1.2; glucose 
11.5; NaHCOs, 25.0; continuously aerated with 95% 
02-5% CO2. Indomethacin (10~tm) was added to the 
buffer solution to block the cyclooxygenase pathway. 
Vessels were dissected free from surrounding tissue 
and cut into rings (2 rain) with a sharp razor blade. 
Rings were mounted in 15ml organ baths containing 
the above mentioned buffer at 37 °C and connected toa 
transducer for measurement of isotonic displacements. 
They were given a preload of 14raN and allowed to 
equilibrate for 45 min, during which time regular 
washings were preformed. All rings were primed and 
checked for viability by evoking an initial contraction 
with 10 btM phenylephrine followed by repeated wash- 
ing and renewed stabilisation for 45 min. Subsequent 
relaxatory studies (below) were all preformed in 10 btM 
phenylephrine-precontracted rings, with different 
series of measurements being separated by repeated 
washings and stabilisation. 
Endothelium dependent and independent relaxations 
In the first series of measurements, all rings were 
stimulated with l~tM bradykinin, followed by sub- 
sequent addition of 10mM sodium nitrite. In the sec- 
ond series of measurements, individual rings were 
stimulated in a parallel fashion with one of the fol- 
lowing different agonists: ATP (10nM-100btM), ADP 
(10nM-100btM), calcium ionitric oxide phore A23187 
(30nM-1 btM), and sodium nitrite (1 btM-10mM). Fol- 
lowing the response to the final concentrations of the 
aforementioned agonists, 10mM sodium nitrite was 
added (except in case sodium nitrite was the first 
agonist). Endothelial-dependency and independency 
for agonist-induced relaxations in IJV and GEA had 
been determined inprevious pilot-experiments. It was 
demonstrated by the loss of relaxation to bradykinin, 
ATP, ADP and A23187 in endothelium-denuded rings 
(data not shown). 
The involvement of nitric oxide was similarly dem- 
onstrated by the loss of relaxation to bradykinin, ATP, 
ADP, A23187 and in endothelium-intact rings in the 
presence of the nitric oxide synthetase inhibitor NG- 
mono-methyl-L-arginine (100btM). Interference by 
agonist-induced release of vasoactive prostaglandins 
was prevented by the continuous presence of indo- 
methacin (10 ~tM) to block formation of cyclo-oxy- 
genase products. Following the final concentration f 
aforementioned agonists, 10 mM sodium nitrite was 
added to demonstrate he relaxatory capacity of the 
ring preparations in the above experimental condition, 
and to exclude possible defects at the level of smooth 
muscle cells to respond to nitric oxide. 
Statistics 
Relaxation-related displacements were calculated as 
percentage of the previously established phenyl- 
ephrine induced contraction. All data are expressed 
as mean-t-standard error of the mean. Differences in 
means were tested for significance using a two-tailed 
Student's t-test or F-ANOVA, and p values <0.05 were 
gained as significant. 
Results 
The GEA is accompanied by gastroepiploic veins (Fig. 
3a), which make it difficult to visualise GEA for the 
implantation procedure. The surgical manipulation of 
the GEA causes pasm, which, by reducing the dia- 
meter to less than lmm, makes the anastomosis dif- 
ficult. We first explored the possibility to use the 
saphous vein as a venous bypass graft. However, in 
this porcine model, the saphenous vein is limited in 
length and has multiple side branches. The internal 
jugular vein, on the other hand, has adequate length 
with almost no side branches. 
All animals survived the experimental period, and 
had an increase in body weight (42.2+0.9 versus 
46.2+ 1.0kg body weight before and after operation; 
p<0.001). Six internal jugular vein grafts and six GEA 
grafts were occluded at harvest 3 weeks after the 
operation. In the first four operated pigs both the GEA 
and IJV were occluded. In pigs five-seven the GEA 
graft or IJV graft was occluded. The graft failures may 
in part be attributed to a learning curve. The remaining 
six patent IJV grafts and the six patent GEA grafts 
were used for histological and functional studies. 
Histology 
Light microscopic examination of the internal jugular 
vein demonstrated a single layer of endothelial cells 
and a media consisting of approximately four layers 
of smooth muscle cells surrounded by collagen and 
elastin. Three weeks after the implantation all vein 
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(A) (B) 
Fig. 2. Light microscopy of internal jugular vein before (A) and after (B) implantation asbypass graft. Note the extensive intimal 
hyperplasia in the vein graft. Verhoeff's elastin staining. Arrows indicates the demarcation between the intima nd the media. Original 
magnification x 20. 
grafts showed an extensive concentric intimal thick- 
ening. Endothelial cells could be identified on the 
luminal surface of the vein grafts. The (myo) fibroblasts 
or smooth muscle cells in the intima were arranged 
in a random pattern within expanded extracellular 
matrix. The media of the vein grafts underwent con- 
centric thickening. 
Medial area was 0.35 __+ 0.04 vs. 3.83 _+ 0.31mm 2 (n = 
6, p<0.0001) before and after implantation, respectively. 
Representative cross-sections of the internal jugular 
vein before and after bypass grafting are shown (Fig. 
2). 
The intima of the gastroepiploic artery consisted of 
a single layer of endothelium with the internal elastic 
lamina. The media consisted of 20-25 concentric layers 
of smooth muscle cells separated by concentric ori- 
entated elastic fibres. Three weeks after implantation 
two GEA grafts had developed no intimal hyperplasia, 
whereas four GEA grafts had developed only few 
small area of intima hyperplasia (Fig. 3b). Both the 
endothelial layer and the internal elastic lamina were 
intact. The media increased in thickness and cellularity 
and the concentric elastic fibres appeared unchanged, 
suggesting that the integrity of the artery was pre- 
served. Medial area was 0.59 + 0.06 vs. 3.14 + 0.21mm 2 
(n=6, p<0.0001) before and after implantation, re- 
spectively. 
The internal jugular vein implanted into the peri- 
pheral circulation caused extensive intimal thickening, 
whereas the GEA reacted mainly with medial thick- 
ening and minimal or absent intimal hyperplasia. The 
thickness of the intima was 644+46 vs. 33 + 11~tm 
(p<0.0001) for IJV grafts and GEA grafts, respectively. 
Thickness of the media was 435 + 98 vs. 448 + 56 ~tm 
(p =0.80) for IJV grafts GEA grafts, respectively. The 
results of dimensional morphometric analysis are 
shown in Fig. 4. 
Endothelial function 
In a number of experiments preceding the present 
study, we established that relaxations induced by ATP, 
ADP, bradykinin (all receptor-dependent) and A23187 
(receptor-independent) i  porcine GEA and IJV were 
suppressible by inhibition of nitric oxide synthetase 
and depend on the presence of the endothelium (data 
not shown). 
The above endothelium-dependent relaxations 
therefore reflect the biological activity of nitric oxide 
released from the stimulated endothelium, and the 
subsequent responsiveness of vascular smooth muscle 
cells to nitric oxide. The latter is reflected by relaxatory 
response to the endothelium-independent vasodilator 
sodium nitrite. In the present study, the receptor- 
dependent relaxations induced by ATP (Fig. 5) and 
ADP (not presented) were significantly decreased in 
GEA and IJV grafts. Similarly, bradykinin-induced 
relaxation (in % precontraction) in GEA was sig- 
nificantly decreased (p<0o001) from 70 _+ 5% (n = 12) to 
27+3% (n =6) after grafting, whereas in IJV it de- 
creased from 58 + 7% (n = 10) to -48  + 11% (n = 6); i.e. 
relaxation in IJV turned into contractions after grafting. 
Receptor-independent stimulation with calcium ion- 
ophore A23187 resulted in comparable relaxatory re- 
sponses in GEA before and after grafting. In contrast, 
A23187 induced relaxations were virtually abolished in 
IJV grafts (Fig. 6). The above changes in endothelium- 
dependent relaxatory responses after grafting seemed 
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(A) (B) 
Fig. 3. Light microscopy of the gastroepiploic artery (arrow) with accompanying veins (A). The right gastroepiploic artery 3 weeks after 
implantation i to the peripheral circulation showed minor intimal hyperplasia (B). Arrows indicate the internal el stic lamina. Tissue 





Fig. 4. Bar graph indicating cross-sectional rea of intima and media 
of pig jugular vein bypass grafts (dark bars) and gastroepiploic 
artery bypass (GEA) grafts (white bars), harvested at 21 days after 
peripheral implantation. Development of intimal hyperplasia was 
significantly less in GEA grafts. Values represent mean _+ s.~.M. 
Asterisk indicates p<0.0001. (11) IJV graft; ([]) GEA graft. 
not to be due to exper imenta l  condit ions or decreased 
vascular  respons iveness to nitric oxide since sod ium 
nitr i te- induced relaxation directly fol lowing ATP/  
ADP/bradyk in in /A23187 was  not decreased either in 
GEA grafts or in IJV grafts (data not presented).  This 
was  conf i rmed by  the relaxatory responses of the r ings 
st imulated with increasing concentrat ions of sod ium 
nitrite, d isp laying an increased rather than decreased 
sensit ivity to nitric oxide after grafting, especial ly in 
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Fig. 5. Endothelium-dependent relaxation to ATP in the gastro- 
epiploic artery (left y axis) and internal jugular vein (right y axis) 
before (control=closed circles; n=9 and n=9 for GEA and IJV 
respectively) and 21 days after (graft=open circles; n=9 and n=5 
for GEA and IJV respectiveiy) grafting. Relaxations are expressed 
as a percentage of phenylefrine-induced precontraction, and data 
represent the mean + S.E.M. Asterisk indicates p<0.05. (O) Control; 
(C)) graft. 
Discussion 
In this exper imenta l  model ,  the gastroepiploic artery 
was  successful ly used as per iphera l  bypass  graft. The 
deve lopment  of int imal hyperp las ia  in the internal 
jugular  vein grafts was  extensive, whereas  int imal 
hyperp las ia  in the gastroepiploic artery grafts was  
min imal  or absent. The results of functional vascular  
studies demonst ra ted  loss of endothel ia l  nitric oxide 
funct ion in the IJV grafts, whi le endothel ia l  capacity 
to generate biological ly active nitric oxide in GEA 
grafts remained  intact. 
Int imal  hyperplas ia ,  the universal  response after 
vein graft implantat ion in the arterial circulation, is 
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Fig. 6. Endothelium-dependent r laxation to calcium inophore 
A23187 in the gastroepiploic artery (left y-axis) and internal jugular 
vein (right y-axis) before (control =closed circles; n= 8 and n = 8 for 
GEA and IJV, respectively) and 21 days after (graft= open circles; 
n = 6 and n = 4 GEA and IJV respectively) grafting. Relaxations are 
expressed asa percentage of phenylephrine-induced pr contraction, 
and data represent the mean + S.r.M. Asterisk indicates p<0.05. (0) 
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Fig. 7. Endothelium-dependent relaxation to sodium nitrite in the 
gastroepiploic artery (left y-axis) and internal jugular vein (right y- 
axis) before (control =closed circles; n= 10 and n = 10 for GEA and 
IJV respectively) and 21 days after (graft=open circles; n=5 and 
n =6 for GEA and IJV, respectively) grafting. Relaxations are ex- 
pressed as a percentage of phenylept-Lrine-induced pr contraction, 
and data represent the mean + S.E.M. Asterisk indicates p<0.05. (0) 
Control; (O) graft. 
held responsible for vein graft stenosis and occlusion 
in the initial years after implantation. 6 Intimal hy- 
perplasia starts with myofibroblast proliferation 2 days 
after graft implantation or arterial wall injury, this is 
followed by extracellular matrix secretion in the second 
week leading to intimal thickening. 7 The minimal or 
absent intimal hyperplasia in GEA grafts after 3 weeks 
suggests that the intimal hyperplasia will remain at 
this low level. This hypothesis is supported by the 
clinical observation that the development of intimal 
hyperplasia in internal mammary arterial bypass grafts 
and gastroepiploic arterial bypass grafts is insignificant 
2 years after implantation and beyond. 8'16 It is hypo- 
thesised that the intimal proliferative response forms 
the basis for vein graft accelerated atherosclerosis, 
an important cause of late vein graft failure. 7'9'~° The 
extensive intimal hyperplasia in the peripheral IJV 
grafts in this study is likely to predispose to graft 
stenosis and accelerated vein graft atherosclerosis. Im- 
provement of peripheral revascularisation especially 
below the knee can be realised by either measures 
to control vein graft intimal hyperplasia or by the 
introduction of alternative bypass conduits. Ex- 
perimental studies reported successful inhibition of 
vein graft intimal hyperplasia with the use of systemic 
or local pharmacologic compounds. 6 So far no clinical 
study reported inhibition of intimal hyperplasia. The 
clinical application of small diameter synthetic vas- 
cular grafts with or without endothelial seeding is still 
disappointing) 1 
The endothelium is an important modulator of the 
vessel tone, prevents blood vessel thrombosis, and 
controls vascular smooth muscle cell proliferation. 2 
Endothelium exercises these functions through the 
production of endothelium derived products like pro- 
stacyclin and nitric oxide. 
Nitric oxide reduces platelet adhesion and is itself 
a potent anti-aggregatory mediator. Both experimental 
and clinical studies revealed that vein grafts in the 
arterial circulation undergo functional changes leading 
to incapacity of production of prostacyclin and nitric 
oxide. 2 Oral suppletion with L-arginine, a precursor 
of nitric oxide, inhibited vein graft intimal hyperplasia 
in an experimental study) 2 This observation further 
stresses the importance of nitric oxide in vein re- 
modelling after bypass grafting. Long-term follow-up 
studies in cardiac surgery have shown that the patency 
rate of predicted and free internal mammary artery 
grafts was better than that of saphenous vein grafts. 8
It is suggested that differences in endothelial function 
may contribute to this higher patency rate among 
arterial grafts than among venous grafts) s Recently, 
we reported the ability of the human GEA to produce 
nitric oxide and the resemblance of the activation and 
behaviour of the 1-arginine pathways in the human 
GEA and the IMA. 4 
In the present study, both receptor-dependent a d 
independent induction of endothelium dependent 
(nitric oxide-mediated) relaxation was markedly im- 
paired in IJV after grafting. This impairment seemed 
not to be due to a defect at the level of vascular smooth 
muscle cells since vascular sensitivity of IJV grafts 
to exogenous nitric oxide was increased rather than 
decreased. Such increased sensitivity to exogenous 
nitric oxide may also be observed in endothelium- 
denuded vascular preparations, and is believed to 
reflect a diminished inhibitory effect of endogenous 
nitric oxide on exogenous nitric oxide. Sodium nitrite 
induced relaxations were also intact in GEA grafts, thus 
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indicating that decreased responsivity to exogenous 
nitric oxide can not account for the decrease in endo- 
thelial receptor elaxation in GEA after grafting. In 
contrast o IJV grafts, receptor independent induction 
of endothelium dependent relaxation was intact in 
GEA graft, suggesting a normal formation of bio- 
logically active nitric oxide. 
These data are indicative for selective alterations at 
endothelial receptor level in arterial grafts, and a gen- 
eral loss in endothelial capacity to generate biologically 
active nitric oxide in venous grafts. This endothelial 
dysfunction may in part explain the extensive intimal 
hyperplasia in the IJV grafts, and the low intimal 
hyperplasia in GEA grafts presumably associated with 
the capacity to produce nitric oxide. Besides the min- 
imal intimal hyperplasia formation and the capacity 
to produce nitric oxide is the low susceptibility of the 
GEA to atherosclerosis; 5 another characteristic making 
the GEA an attractive alternative for peripheral re- 
construction. In the human situation approximately 
16-26cm of the GEA can be used for re- 
vascularisation. 14 In the clinical setting the flow rates 
of GEA grafts for coronary bypass grafting ranged 
from 141-210ml/min depending on the size of the 
distal anastomosis. 14 Another human study dem- 
onstrated that the average intraoperative flow rates in 
femorotibial nd femoropopliteal venous bypass grafts 
were 150-180ml/min, respectively. 15 These data in- 
dicate that, despite the small diameter of the GEA graft, 
this arterial graft is capable of transporting equivalent 
blood volumes to venous grafts. The problem of spasm 
of the GEA graft during implantation can clinically be 
prevented by the intraluminal use of papavarine and 
verapamil. 14 Laparoscopic preparation of the GEA may 
further facilitate its use for human peripheral re- 
construction. 
In summary, we have shown that the gastroepiploic 
artery can be used as a peripheral bypass graft. The 
investigated parameters, thought o be crucial for long- 
term graft patency, were significantly better in the 
GEA grafts than in the IJV grafts in this animal model. 
These results encourage the use of the human GEA 
for reconstruction of arteries in the lower limb or foot. 
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